Maple-Brown Abbott Australian Small Companies Fund

The Fund is actively managed and is primarily invested in companies listed (or expected to be listed) on an Australian securities exchange which, at the time they are first invested, are not included in the S&P/ASX 100 Index and have a minimum market capitalisation of $100 million.

We believe that company earnings drive share prices over the medium-term. We use a disciplined fundamental research process to identify undervalued companies where we have conviction in medium-term earnings delivery. We focus on earnings-based valuations, assessment of how sustainable a company’s business model is and consideration of earnings risk. We believe that this focus can deliver strong and consistent returns over the long-term. Given the breadth of the Australian small companies market, we believe companies with this profile can be found at any point in the market cycle.

The portfolio managers have a proven and repeatable investment process, focused on in-depth fundamental research at the company level.* This approach is designed to create a portfolio of compelling high conviction ideas for our investors.

We typically hold 30–50 stocks which score well on combined earnings-based valuation and sustainability measures, with the focus on diversification and stock specific risk management.

*The past performance and experience of the portfolio managers was achieved managing a different fund with substantially the same investment strategy as the Fund. Past performance is not a reliable indicator of future performance.

Fund facts
Inception date24/06/2022Distribution frequencyAnnually
BenchmarkS&P/ASX Small Ordinaries Total Return IndexMinimum initial application$ 20,000
APIR codeMPL1241AUManagement fees and costs %*^1.10Performance fee^ 15% of the Fund’s outperformance of the Benchmark
Pricing frequency & cut-offDaily/2pm Sydney time on a Business DayBuy/Sell spread %^0.25/0.25

*Management fees and costs for the Fund are made up of the management fee, indirect costs (if any) and estimated recoverable expenses.
^Additional fees and costs may also apply in relation to an investment in the Fund. For a full description of the fees and costs refer to the Product Disclosure Statement and Additional Information Booklet for the Fund.

Portfolio Managers

A team of experienced and dedicated investment professionals.

Phillip Hudak | Co-Portfolio Manager, Australian Small Companies | Maple-Brown Abbott
Phillip Hudak
Co-Portfolio Manager, Australian Small Companies
Matt Griffin | Co-Portfolio Manager, Australian Small Companies | Maple-Brown Abbott
Matt Griffin
Co-Portfolio Manager, Australian Small Companies

Fund performance^

as at 30/04/2024

1 mth %3 mths %1 yr % p.a.Since inception % p.a.*

^Past performance is not a reliable indicator of future performance. No warranty can be given for future performance. Returns are volatile and may fluctuate quickly and significantly. Total return is based on the movement in net asset value per unit plus distributions and is before tax and after all fees and charges. Imputation and foreign income tax offsets are not included in the performance figures.
Source: Maple-Brown Abbott and S&P
*Inception date is 24 June 2022

Unit price

as at 21/05/2024

Download unit price history
Application priceNet asset valueRedemption price
$ 1.4163$ 1.4128$ 1.4093

Forms and fund information

Fund ratings 


Lonsec Research Recommended logo
Morningstar Silver medallist rating
Zenith recommended logo

The Lonsec rating issued 10/2023 is published by Lonsec Research Pty Ltd ABN 11 151 658 561 AFSL 421 445 (Lonsec). Ratings are general advice only, and have been prepared without taking account of your objectives, financial situation or needs. Consider your personal circumstances, read the product disclosure statement and seek independent financial advice before investing. The rating is not a recommendation to purchase, sell or hold any product. Past performance information is not indicative of future performance. Ratings are subject to change without notice and Lonsec assumes no obligation to update. Lonsec uses objective criteria and receives a fee from the Fund Manager. Visit for ratings information and to access the full report. ©2023 Lonsec. All rights reserved.

Morningstar Medalist Rating(TM) 
Assigned as of 15/12/23
Analyst Driven %  100
Data Coverage % 100

Fund Maple-Brown Abbott Australian Small Companies received a Morningstar Medalist Rating(TM) of 'Silver' on 15/12/23.

© 2024 Morningstar, Inc. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. This report or data has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or New Zealand wholesale clients of Morningstar Research Ltd, subsidiaries of Morningstar, Inc. Any general advice has been provided without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide at You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Morningstar’s publications, ratings and products should be viewed as an additional investment resource, not as your sole source of information. Morningstar’s full research reports are the source of any Morningstar Ratings and are available from Morningstar or your adviser. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a financial adviser.

The Zenith Investment Partners (ABN 27 103 132 672, AFS Licence 226872) (“Zenith”) rating (assigned MPL1241AU February 2024) referred to in this piece is limited to “General Advice” (s766B Corporations Act 2001) for Wholesale clients only. This advice has been prepared without taking into account the objectives, financial situation or needs of any individual, including target markets of financial products, where applicable, and is subject to change at any time without prior notice. It is not a specific recommendation to purchase, sell or hold the relevant product(s). Investors should seek independent financial advice before making an investment decision and should consider the appropriateness of this advice in light of their own objectives, financial situation and needs. Investors should obtain a copy of, and consider the PDS or offer document before making any decision and refer to the full Zenith Product Assessment available on the Zenith website. Past performance is not an indication of future performance. Zenith usually charges the product issuer, fund manager or related party to conduct Product Assessments. Full details regarding Zenith’s methodology, ratings definitions and regulatory compliance are available on our Product Assessments and at Fund Research Regulatory Guidelines.

Interested in investing with us?